Masterfox Consulting Group (MCG)

30% of fluorinating reagents are consumed in all agrochemicals and 20% of all pharmaceuticals contain fluorine, The market is expected to grow at a CAGR of 8.2% during the forecast period 2019-2026. The growing importance of fluorinating compounds in medicinal chemistry, biology, and organic synthesisoffers a major impetus to the discovery of new and mid fluorinating agents that can operate safely and efficiently. Many electrophilic fluorinating agents have been used in synthesis in various end-use industries including pharmaceuticals and agricultural compounds; however, most of these agents are highly aggressive, unstable and require special equipment and care for safe handling. Fluorinating agentsare toxic and corrosive in nature andare well known to have a transformative effect on many drugs and medicines, helping to make them more powerful, selective and metabolically stable. Currently, almostone-fifth of pharmaceutical industryproducts contain fluorine, including around a

Two-fold Growth in Personal Care End-Use Industry Soar the Demand for Carbomer Market Carbomer is a trading name of polyacrylic acid, this polymer product is characterized by water solubility and absorbability. Carbomer is found in solid and liquid state and widely used as a dispersant, thickener, antiscalant, binder and as intermediate in numerous end-user industries. The production of carbomer is widely dependent on its parent market acrylic acid. The increasing use of super absorbent in wide applicationsis likely to drive the demand for carbomer as they can absorb water up to 500 times its own weight.Additionally, liquid carbomer is readily dissolved in water and consumed in the treatment of sewage water and wastewater effluents, which in turn, remains one of the significant driving factors for the growth of the market. Moreover, the major key players of the market are investing in research and development in polyacrylic acid and its derivatives with the purpose of incr

Global Non-Insulin Therapies Market is expected to grow with a CAGR of 6.6% by 2020-2027 Global Non-InsulinTherapies Market   is projected to expand with a CAGR of 6.6 % during the forecast timeline, 2020 to 2027. The Non-Insulin Therapies market comprises of Oral non-insulin drugs such as Thiazolidinediones (TZDs), Insulin secretagogues, Alpha-glucosidase inhibitors (AGIs), Sulfonylureas, Dipeptidyl peptidase-4 (DPP-4) inhibitors, Sodium-glucose cotransporter-2 (SGLT2) inhibitors, Glinides/Meglitinides, Metformin, Biguanides and Injectable non-insulin drugs such as Glucagon-like peptide-1 (GLP-1) agonists, Amylin Agonists. U.S non-insulin therapies market holds lions share in the global market. In fact, it accounted for nearly more than 31% of market share in 2018 and is positioned to expand at a notable growth rate. Japan non-insulin therapies market being another mature market is expected to expand at a modest growth rate. Masterfox Consulting Group (MCG) has introduced a

Global Ambulatory Surgical Centers Market is expected to growwith a CAGR of 10% by 2020-2027 Global AmbulatorySurgical Centers Market   is projected to expand with a CAGR of 5.1% during the forecast timeline, 2020 to 2027. The Ambulatory Surgical Centers market comprises ownership types such as Physician Only, Hospital Only, Corporation Only, Physician & Hospital, Physician & Corporation, and Hospital & Corporation. The Ambulatory Surgical Centers offer surgeries such as Dental, Otolaryngology, Endoscopy, Obstetrics/Gynecology, Ophthalmology, Orthopedic, Cardiovascular, Neurology, Plastic Surgery, Podiatry and Others. Asia Pacific Ambulatory Surgical Centers market is expected to grow with a highest CAGR of over 7% during the forecast period, 2019-2027, and it was valued over USD 9 billion in 2018. ChinaAmbulatory Surgical Centers market is poised to expand exponentially over the coming 5-7 years, owing to high number of injuries, road accidents, development of ne